Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myocytes, Cardiac | 12 | 2024 | 88 | 2.800 |
Why?
|
Induced Pluripotent Stem Cells | 9 | 2024 | 139 | 1.200 |
Why?
|
Myocardium | 8 | 2023 | 264 | 1.130 |
Why?
|
Lab-On-A-Chip Devices | 9 | 2024 | 20 | 1.100 |
Why?
|
Tissue Engineering | 8 | 2024 | 134 | 1.070 |
Why?
|
Angiotensin II | 2 | 2024 | 23 | 0.960 |
Why?
|
Vaccines | 1 | 2023 | 95 | 0.780 |
Why?
|
Autophagy | 2 | 2013 | 213 | 0.690 |
Why?
|
Cardiomyopathies | 1 | 2021 | 119 | 0.650 |
Why?
|
Heart Diseases | 1 | 2022 | 206 | 0.640 |
Why?
|
Nanoparticles | 1 | 2023 | 493 | 0.570 |
Why?
|
Drug Evaluation, Preclinical | 4 | 2021 | 89 | 0.500 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2013 | 289 | 0.450 |
Why?
|
Animals, Newborn | 1 | 2013 | 230 | 0.410 |
Why?
|
Fibrosis | 3 | 2022 | 153 | 0.400 |
Why?
|
Transcriptional Activation | 1 | 2013 | 188 | 0.390 |
Why?
|
Proto-Oncogene Proteins | 1 | 2013 | 318 | 0.370 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2013 | 620 | 0.320 |
Why?
|
Proteomics | 2 | 2021 | 263 | 0.310 |
Why?
|
Drug Discovery | 2 | 2020 | 89 | 0.300 |
Why?
|
Membrane Proteins | 1 | 2013 | 850 | 0.280 |
Why?
|
Microtechnology | 2 | 2023 | 5 | 0.250 |
Why?
|
Organoids | 2 | 2024 | 40 | 0.230 |
Why?
|
Humans | 21 | 2025 | 59438 | 0.230 |
Why?
|
Heart Failure | 1 | 2012 | 853 | 0.230 |
Why?
|
RNA, Messenger | 2 | 2025 | 1469 | 0.230 |
Why?
|
Needles | 1 | 2025 | 65 | 0.230 |
Why?
|
Zeolites | 1 | 2024 | 3 | 0.220 |
Why?
|
Cardiac Myosins | 1 | 2024 | 22 | 0.220 |
Why?
|
Myosin Heavy Chains | 1 | 2024 | 42 | 0.220 |
Why?
|
Coculture Techniques | 2 | 2021 | 95 | 0.220 |
Why?
|
Proteome | 2 | 2021 | 141 | 0.210 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2023 | 35 | 0.210 |
Why?
|
Models, Cardiovascular | 3 | 2018 | 76 | 0.200 |
Why?
|
Heart | 2 | 2024 | 274 | 0.190 |
Why?
|
Relaxin | 1 | 2021 | 2 | 0.190 |
Why?
|
Losartan | 1 | 2021 | 18 | 0.190 |
Why?
|
Signal Transduction | 3 | 2020 | 2901 | 0.190 |
Why?
|
Cardiotonic Agents | 1 | 2021 | 50 | 0.180 |
Why?
|
Vaccination | 1 | 2023 | 335 | 0.180 |
Why?
|
Perfusion | 1 | 2021 | 79 | 0.180 |
Why?
|
Animals | 8 | 2025 | 19665 | 0.180 |
Why?
|
Ventricular Remodeling | 1 | 2021 | 79 | 0.180 |
Why?
|
Blood Vessels | 1 | 2021 | 62 | 0.180 |
Why?
|
Drug Delivery Systems | 1 | 2023 | 312 | 0.170 |
Why?
|
Tissue Scaffolds | 4 | 2024 | 79 | 0.160 |
Why?
|
Cell Line | 2 | 2021 | 1984 | 0.160 |
Why?
|
Fibroblasts | 1 | 2021 | 377 | 0.160 |
Why?
|
Cell Survival | 1 | 2021 | 559 | 0.160 |
Why?
|
Organ Culture Techniques | 1 | 2019 | 68 | 0.160 |
Why?
|
Recombinant Proteins | 1 | 2021 | 691 | 0.160 |
Why?
|
Tissue Culture Techniques | 1 | 2019 | 31 | 0.160 |
Why?
|
Pandemics | 1 | 2023 | 617 | 0.150 |
Why?
|
Embryonic Stem Cells | 1 | 2019 | 151 | 0.150 |
Why?
|
Pilot Projects | 1 | 2021 | 915 | 0.150 |
Why?
|
Cell Culture Techniques | 1 | 2019 | 178 | 0.140 |
Why?
|
Cardiomyopathy, Hypertrophic | 2 | 2024 | 753 | 0.140 |
Why?
|
Cells, Cultured | 3 | 2019 | 2095 | 0.130 |
Why?
|
Mice | 3 | 2021 | 10300 | 0.130 |
Why?
|
Disease Models, Animal | 3 | 2020 | 2051 | 0.110 |
Why?
|
Apoptosis | 2 | 2024 | 1033 | 0.110 |
Why?
|
Mitochondria, Heart | 1 | 2013 | 13 | 0.110 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2013 | 23 | 0.110 |
Why?
|
Cell Hypoxia | 1 | 2013 | 42 | 0.110 |
Why?
|
Myocardial Ischemia | 1 | 2013 | 111 | 0.100 |
Why?
|
Mitochondrial Proteins | 1 | 2013 | 100 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2012 | 99 | 0.100 |
Why?
|
Blotting, Western | 1 | 2013 | 584 | 0.100 |
Why?
|
Rats, Sprague-Dawley | 1 | 2013 | 574 | 0.090 |
Why?
|
Microscopy, Fluorescence | 1 | 2013 | 394 | 0.090 |
Why?
|
Lysosomes | 1 | 2012 | 160 | 0.090 |
Why?
|
Cardiovascular Diseases | 1 | 2018 | 789 | 0.090 |
Why?
|
Rats | 1 | 2013 | 1911 | 0.080 |
Why?
|
Injections, Intradermal | 1 | 2025 | 7 | 0.060 |
Why?
|
Microinjections | 1 | 2025 | 67 | 0.060 |
Why?
|
Swine | 1 | 2025 | 355 | 0.060 |
Why?
|
Sarcomeres | 1 | 2024 | 51 | 0.060 |
Why?
|
Extracellular Vesicles | 1 | 2024 | 41 | 0.050 |
Why?
|
Cell Differentiation | 2 | 2019 | 1304 | 0.050 |
Why?
|
Spike Glycoprotein, Coronavirus | 1 | 2024 | 95 | 0.050 |
Why?
|
Microfluidics | 1 | 2023 | 22 | 0.050 |
Why?
|
Myosins | 1 | 2024 | 110 | 0.050 |
Why?
|
Endosomes | 1 | 2024 | 170 | 0.050 |
Why?
|
Adjuvants, Immunologic | 1 | 2024 | 224 | 0.050 |
Why?
|
Biocompatible Materials | 1 | 2023 | 141 | 0.050 |
Why?
|
Genotype | 1 | 2024 | 619 | 0.050 |
Why?
|
Endothelial Cells | 1 | 2023 | 173 | 0.050 |
Why?
|
Toll-Like Receptors | 1 | 2024 | 426 | 0.050 |
Why?
|
Human Umbilical Vein Endothelial Cells | 1 | 2021 | 38 | 0.050 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2020 | 40 | 0.040 |
Why?
|
Cytokines | 1 | 2024 | 912 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2024 | 697 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 1 | 2020 | 170 | 0.040 |
Why?
|
Dimethylpolysiloxanes | 1 | 2019 | 14 | 0.040 |
Why?
|
Electrophysiological Phenomena | 1 | 2019 | 20 | 0.040 |
Why?
|
Phosphoproteins | 1 | 2020 | 212 | 0.040 |
Why?
|
Polystyrenes | 1 | 2019 | 32 | 0.040 |
Why?
|
Elastic Modulus | 1 | 2019 | 36 | 0.040 |
Why?
|
Action Potentials | 1 | 2019 | 101 | 0.040 |
Why?
|
Liver | 1 | 2023 | 796 | 0.040 |
Why?
|
Pluripotent Stem Cells | 1 | 2019 | 68 | 0.040 |
Why?
|
MicroRNAs | 1 | 2024 | 618 | 0.040 |
Why?
|
Phosphorylation | 1 | 2020 | 885 | 0.040 |
Why?
|
Physical Stimulation | 1 | 2017 | 29 | 0.040 |
Why?
|
Equipment Design | 1 | 2018 | 330 | 0.030 |
Why?
|
Electric Stimulation | 1 | 2017 | 132 | 0.030 |
Why?
|
Computer Simulation | 1 | 2018 | 459 | 0.030 |
Why?
|
Hydrogels | 1 | 2017 | 110 | 0.030 |
Why?
|
Child | 1 | 2024 | 4194 | 0.030 |
Why?
|
Models, Biological | 1 | 2019 | 1143 | 0.030 |
Why?
|
Adult | 1 | 2023 | 15696 | 0.020 |
Why?
|
Male | 1 | 2024 | 27776 | 0.010 |
Why?
|
Female | 1 | 2024 | 30758 | 0.010 |
Why?
|